Upgrade to SI Premium - Free Trial

Arcturus Therapeutics (ARCT)

7.33 +0.36 (5.16%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/10/26)

Latest Headlines

Form 4 Arcturus Therapeutics For: Jun 05 Filed by: HOLMES EDWARD W June 15, 2026 5:02 PM - SEC Filing Form 4 Arcturus Therapeutics For: Jun 05 Filed by: FARRELL PETER C June 15, 2026 5:02 PM - SEC Filing Form 4 Arcturus Therapeutics For: Jun 05 Filed by: BARLOW JAMES F June 15, 2026 5:02 PM - SEC Filing Form 4 Arcturus Therapeutics For: Jun 05 Filed by: Markels John June 15, 2026 5:01 PM - SEC Filing Form 4 Arcturus Therapeutics For: Jun 05 Filed by: Slaoui Moncef June 15, 2026 5:01 PM - SEC Filing Form 4 Arcturus Therapeutics For: Jun 05 Filed by: Marquet Magda June 15, 2026 5:01 PM - SEC Filing Form 4 Arcturus Therapeutics For: Jun 05 Filed by: Marantz Jing L. June 15, 2026 5:00 PM - SEC Filing Form 8-K Arcturus Therapeutics For: Jun 05 June 5, 2026 5:21 PM - SEC Filing Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference May 26, 2026 4:01 PM - BizWire Form 4 Arcturus Therapeutics For: May 01 Filed by: MULROY DENNIS May 7, 2026 4:35 PM - SEC Filing Form 3 Arcturus Therapeutics For: May 01 Filed by: MULROY DENNIS May 7, 2026 4:34 PM - SEC Filing Form 10-Q Arcturus Therapeutics For: Mar 31 May 7, 2026 4:16 PM - SEC Filing Form 8-K Arcturus Therapeutics For: May 01 May 7, 2026 4:10 PM - SEC Filing Arcturus Therapeutics (ARCT) Tops Q1 EPS by 17c May 7, 2026 4:03 PM - StreetInsider Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress May 7, 2026 4:01 PM - BizWire Form SCHEDULE 13G/A Arcturus Therapeutics Filed by: ARK Investment Management LLC May 7, 2026 3:38 PM - SEC Filing Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026 April 27, 2026 4:01 PM - BizWire Form DEF 14A Arcturus Therapeutics For: Jun 05 April 24, 2026 4:05 PM - SEC Filing When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech April 20, 2026 8:30 AM - Globe NewsWire Form SCHEDULE 13G/A Arcturus Therapeutics Filed by: VANGUARD GROUP INC March 26, 2026 3:57 PM - SEC Filing B.Riley Starts Arcturus Therapeutics (ARCT) at Buy March 18, 2026 12:54 AM - StreetInsider Full Article List